J K Pharmachem Ltd PE Ratio

J K Pharmachem PE Ratio

Image

J K Pharmachem Ltd

NSE: JKPHARMA

PE

-

Last updated on: Sep 08, 2026

Key Highlights

  • The P/E Ratio of J K Pharmachem Ltd is 0 as of 08 Sep 06 .

Historical P/B Ratio of J K Pharmachem Ltd

No data available

Company Fundamentals for J K Pharmachem Ltd

Image

J K Pharmachem Ltd

NSE: JKPHARMA

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of J K Pharmachem Ltd

1M

1Y

3Y

5Y

Monitoring J K Pharmachem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Sep 20061.79
07 Sep 20061.82
06 Sep 20061.83
05 Sep 20061.9
04 Sep 20061.86
01 Sep 20061.78
31 Aug 20061.79
30 Aug 20061.77
29 Aug 20061.85
28 Aug 20061.94

BlinkX Score for J K Pharmachem Ltd

Asset Value vs Market Value of J K Pharmachem Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Key Valuation Metric of J K Pharmachem Ltd

X

Historical Market Cap of J K Pharmachem Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of J K Pharmachem Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of J K Pharmachem Ltd

No data available

* All values are in %

About J K Pharmachem Ltd

  • Jointly promoted by J K Industries and TIDCO, J K Pharmachem manufactures drugs and pharmaceuticals.
  • It entered the capital market in Oct.'94 to part-finance the setting up of a plant to manufacture 1250 MMU P.a of pencillin-G, based on a microbial strain from the technical collaborators -- IGC (Cyprus), Cyprus -- a wholly-owned subsidiary of ICN Galenika.
  • Commercial production at this plant commenced in Oct.'95. The company has a tie-up with ICN Galenika, part of the ICN Pharmaceuticals group (one of the pioneering manufacturers of pencillin-G), to set up a 1250-mmu capacity plant. It has already produced international standard penicillin with Indian raw materials, at its collaborator's plant which is among the best in the world.
  • In addition, J K Pharmachem had set-up its own R&D activity well in advance for future development in the field of bio-technology.

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions